Dr. Oz asks Dr. Hotez about the FDA’s new guidelines that require drug manufacturers to follow clinical trial participants for at least two months, and how that will affect vaccine development.
Dr. Oz asks Dr. Hotez about the FDA’s new guidelines that require drug manufacturers to follow clinical trial participants for at least two months, and how that will affect vaccine development.